Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach Article Swipe
Ryan M. Kramer
,
Michelle Archer
,
Mark T. Orr
,
Natasha Dubois Cauwelaert
,
Elyse A. Beebe
,
Po‐Wei Huang
,
Quinton M. Dowling
,
Alicia M. Schwartz
,
Dawn M. Fedor
,
Thomas S. Vedvick
,
Christopher B. Fox
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.2147/ijn.s159839
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.2147/ijn.s159839
These efforts will aid in the development of a platform formulation for use with other similar vaccines.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.2147/ijn.s159839
- https://www.dovepress.com/getfile.php?fileID=42837
- OA Status
- gold
- Cited By
- 41
- References
- 27
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2810532210
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2810532210Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2147/ijn.s159839Digital Object Identifier
- Title
-
Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approachWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-06-01Full publication date if available
- Authors
-
Ryan M. Kramer, Michelle Archer, Mark T. Orr, Natasha Dubois Cauwelaert, Elyse A. Beebe, Po‐Wei Huang, Quinton M. Dowling, Alicia M. Schwartz, Dawn M. Fedor, Thomas S. Vedvick, Christopher B. FoxList of authors in order
- Landing page
-
https://doi.org/10.2147/ijn.s159839Publisher landing page
- PDF URL
-
https://www.dovepress.com/getfile.php?fileID=42837Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.dovepress.com/getfile.php?fileID=42837Direct OA link when available
- Concepts
-
Thermostability, Adjuvant, Immunogenicity, Tuberculosis vaccines, Mycobacterium tuberculosis, Freeze-drying, Chemistry, Excipient, Biology, Antigen, Chromatography, Tuberculosis, Biochemistry, Medicine, Immunology, Enzyme, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
41Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 4, 2023: 9, 2022: 6, 2021: 8Per-year citation counts (last 5 years)
- References (count)
-
27Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2810532210 |
|---|---|
| doi | https://doi.org/10.2147/ijn.s159839 |
| ids.doi | https://doi.org/10.2147/ijn.s159839 |
| ids.mag | 2810532210 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/29983563 |
| ids.openalex | https://openalex.org/W2810532210 |
| fwci | 2.03498763 |
| mesh[0].qualifier_ui | Q000494 |
| mesh[0].descriptor_ui | D000276 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | pharmacology |
| mesh[0].descriptor_name | Adjuvants, Immunologic |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000818 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Animals |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000917 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Antibody Formation |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D002626 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Chemistry, Pharmaceutical |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D000067493 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Dynamic Light Scattering |
| mesh[5].qualifier_ui | Q000737 |
| mesh[5].descriptor_ui | D004655 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | chemistry |
| mesh[5].descriptor_name | Emulsions |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D005079 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Excipients |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005260 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Female |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D005612 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Freeze Drying |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D006863 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Hydrogen-Ion Concentration |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D007111 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Immunity, Cellular |
| mesh[11].qualifier_ui | Q000737 |
| mesh[11].descriptor_ui | D008055 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | chemistry |
| mesh[11].descriptor_name | Lipids |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D008810 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Mice, Inbred C57BL |
| mesh[13].qualifier_ui | Q000276 |
| mesh[13].descriptor_ui | D009169 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | immunology |
| mesh[13].descriptor_name | Mycobacterium tuberculosis |
| mesh[14].qualifier_ui | Q000737 |
| mesh[14].descriptor_ui | D053758 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | chemistry |
| mesh[14].descriptor_name | Nanoparticles |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D009391 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Nephelometry and Turbidimetry |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D010316 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Particle Size |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D013696 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Temperature |
| mesh[18].qualifier_ui | Q000276 |
| mesh[18].descriptor_ui | D014376 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | immunology |
| mesh[18].descriptor_name | Tuberculosis |
| mesh[19].qualifier_ui | Q000473 |
| mesh[19].descriptor_ui | D014376 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | pathology |
| mesh[19].descriptor_name | Tuberculosis |
| mesh[20].qualifier_ui | Q000276 |
| mesh[20].descriptor_ui | D032581 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | immunology |
| mesh[20].descriptor_name | Tuberculosis Vaccines |
| mesh[21].qualifier_ui | Q000494 |
| mesh[21].descriptor_ui | D000276 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | pharmacology |
| mesh[21].descriptor_name | Adjuvants, Immunologic |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D000818 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Animals |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000917 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Antibody Formation |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D002626 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Chemistry, Pharmaceutical |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D000067493 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Dynamic Light Scattering |
| mesh[26].qualifier_ui | Q000737 |
| mesh[26].descriptor_ui | D004655 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | chemistry |
| mesh[26].descriptor_name | Emulsions |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D005079 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Excipients |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D005260 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Female |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D005612 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Freeze Drying |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D006863 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Hydrogen-Ion Concentration |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D007111 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Immunity, Cellular |
| mesh[32].qualifier_ui | Q000737 |
| mesh[32].descriptor_ui | D008055 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | chemistry |
| mesh[32].descriptor_name | Lipids |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D008810 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Mice, Inbred C57BL |
| mesh[34].qualifier_ui | Q000276 |
| mesh[34].descriptor_ui | D009169 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | immunology |
| mesh[34].descriptor_name | Mycobacterium tuberculosis |
| mesh[35].qualifier_ui | Q000737 |
| mesh[35].descriptor_ui | D053758 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | chemistry |
| mesh[35].descriptor_name | Nanoparticles |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D009391 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Nephelometry and Turbidimetry |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D010316 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Particle Size |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D013696 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Temperature |
| mesh[39].qualifier_ui | Q000276 |
| mesh[39].descriptor_ui | D014376 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | immunology |
| mesh[39].descriptor_name | Tuberculosis |
| mesh[40].qualifier_ui | Q000473 |
| mesh[40].descriptor_ui | D014376 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | pathology |
| mesh[40].descriptor_name | Tuberculosis |
| mesh[41].qualifier_ui | Q000276 |
| mesh[41].descriptor_ui | D032581 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | immunology |
| mesh[41].descriptor_name | Tuberculosis Vaccines |
| type | article |
| title | Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach |
| biblio.issue | |
| biblio.volume | Volume 13 |
| biblio.last_page | 3711 |
| biblio.first_page | 3689 |
| topics[0].id | https://openalex.org/T11124 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9991999864578247 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Protein purification and stability |
| topics[1].id | https://openalex.org/T11016 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9984999895095825 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2741 |
| topics[1].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[1].display_name | Monoclonal and Polyclonal Antibodies Research |
| topics[2].id | https://openalex.org/T10602 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9922000169754028 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Glycosylation and Glycoproteins Research |
| is_xpac | False |
| apc_list.value | 2836 |
| apc_list.currency | USD |
| apc_list.value_usd | 2836 |
| apc_paid.value | 2836 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2836 |
| concepts[0].id | https://openalex.org/C2781216036 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8442174196243286 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q902494 |
| concepts[0].display_name | Thermostability |
| concepts[1].id | https://openalex.org/C2777863537 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7703261375427246 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q357896 |
| concepts[1].display_name | Adjuvant |
| concepts[2].id | https://openalex.org/C2780868878 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6555229425430298 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1660197 |
| concepts[2].display_name | Immunogenicity |
| concepts[3].id | https://openalex.org/C2779078216 |
| concepts[3].level | 4 |
| concepts[3].score | 0.5291353464126587 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7850848 |
| concepts[3].display_name | Tuberculosis vaccines |
| concepts[4].id | https://openalex.org/C2777975735 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5102293491363525 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q130971 |
| concepts[4].display_name | Mycobacterium tuberculosis |
| concepts[5].id | https://openalex.org/C84199377 |
| concepts[5].level | 2 |
| concepts[5].score | 0.47932755947113037 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q723912 |
| concepts[5].display_name | Freeze-drying |
| concepts[6].id | https://openalex.org/C185592680 |
| concepts[6].level | 0 |
| concepts[6].score | 0.46901363134384155 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[6].display_name | Chemistry |
| concepts[7].id | https://openalex.org/C2777239854 |
| concepts[7].level | 2 |
| concepts[7].score | 0.412466824054718 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q902638 |
| concepts[7].display_name | Excipient |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.29116153717041016 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C147483822 |
| concepts[9].level | 2 |
| concepts[9].score | 0.2861020565032959 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q103537 |
| concepts[9].display_name | Antigen |
| concepts[10].id | https://openalex.org/C43617362 |
| concepts[10].level | 1 |
| concepts[10].score | 0.24247616529464722 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q170050 |
| concepts[10].display_name | Chromatography |
| concepts[11].id | https://openalex.org/C2781069245 |
| concepts[11].level | 2 |
| concepts[11].score | 0.19472795724868774 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12204 |
| concepts[11].display_name | Tuberculosis |
| concepts[12].id | https://openalex.org/C55493867 |
| concepts[12].level | 1 |
| concepts[12].score | 0.19389662146568298 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[12].display_name | Biochemistry |
| concepts[13].id | https://openalex.org/C71924100 |
| concepts[13].level | 0 |
| concepts[13].score | 0.14911246299743652 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[13].display_name | Medicine |
| concepts[14].id | https://openalex.org/C203014093 |
| concepts[14].level | 1 |
| concepts[14].score | 0.11742663383483887 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[14].display_name | Immunology |
| concepts[15].id | https://openalex.org/C181199279 |
| concepts[15].level | 2 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q8047 |
| concepts[15].display_name | Enzyme |
| concepts[16].id | https://openalex.org/C142724271 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[16].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/thermostability |
| keywords[0].score | 0.8442174196243286 |
| keywords[0].display_name | Thermostability |
| keywords[1].id | https://openalex.org/keywords/adjuvant |
| keywords[1].score | 0.7703261375427246 |
| keywords[1].display_name | Adjuvant |
| keywords[2].id | https://openalex.org/keywords/immunogenicity |
| keywords[2].score | 0.6555229425430298 |
| keywords[2].display_name | Immunogenicity |
| keywords[3].id | https://openalex.org/keywords/tuberculosis-vaccines |
| keywords[3].score | 0.5291353464126587 |
| keywords[3].display_name | Tuberculosis vaccines |
| keywords[4].id | https://openalex.org/keywords/mycobacterium-tuberculosis |
| keywords[4].score | 0.5102293491363525 |
| keywords[4].display_name | Mycobacterium tuberculosis |
| keywords[5].id | https://openalex.org/keywords/freeze-drying |
| keywords[5].score | 0.47932755947113037 |
| keywords[5].display_name | Freeze-drying |
| keywords[6].id | https://openalex.org/keywords/chemistry |
| keywords[6].score | 0.46901363134384155 |
| keywords[6].display_name | Chemistry |
| keywords[7].id | https://openalex.org/keywords/excipient |
| keywords[7].score | 0.412466824054718 |
| keywords[7].display_name | Excipient |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.29116153717041016 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/antigen |
| keywords[9].score | 0.2861020565032959 |
| keywords[9].display_name | Antigen |
| keywords[10].id | https://openalex.org/keywords/chromatography |
| keywords[10].score | 0.24247616529464722 |
| keywords[10].display_name | Chromatography |
| keywords[11].id | https://openalex.org/keywords/tuberculosis |
| keywords[11].score | 0.19472795724868774 |
| keywords[11].display_name | Tuberculosis |
| keywords[12].id | https://openalex.org/keywords/biochemistry |
| keywords[12].score | 0.19389662146568298 |
| keywords[12].display_name | Biochemistry |
| keywords[13].id | https://openalex.org/keywords/medicine |
| keywords[13].score | 0.14911246299743652 |
| keywords[13].display_name | Medicine |
| keywords[14].id | https://openalex.org/keywords/immunology |
| keywords[14].score | 0.11742663383483887 |
| keywords[14].display_name | Immunology |
| language | en |
| locations[0].id | doi:10.2147/ijn.s159839 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S101287785 |
| locations[0].source.issn | 1176-9114, 1178-2013 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1176-9114 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | International Journal of Nanomedicine |
| locations[0].source.host_organization | https://openalex.org/P4310320348 |
| locations[0].source.host_organization_name | Dove Medical Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320348 |
| locations[0].source.host_organization_lineage_names | Dove Medical Press |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.dovepress.com/getfile.php?fileID=42837 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | International Journal of Nanomedicine |
| locations[0].landing_page_url | https://doi.org/10.2147/ijn.s159839 |
| locations[1].id | pmid:29983563 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | International journal of nanomedicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/29983563 |
| locations[2].id | pmh:oai:europepmc.org:4986257 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | http://europepmc.org/pmc/articles/PMC6028350 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:6028350 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | cc-by |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/cc-by |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Int J Nanomedicine |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6028350 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5107341610 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2749-5301 |
| authorships[0].author.display_name | Ryan M. Kramer |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1330732676 |
| authorships[0].affiliations[0].raw_affiliation_string | Fox Infectious Disease research Institute, seattle, Wa, Usa |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I1330732676 |
| authorships[0].affiliations[1].raw_affiliation_string | Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[0].institutions[0].id | https://openalex.org/I1330732676 |
| authorships[0].institutions[0].ror | https://ror.org/03y4myd35 |
| authorships[0].institutions[0].type | nonprofit |
| authorships[0].institutions[0].lineage | https://openalex.org/I1330732676 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Infectious Disease Research Institute |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ryan M Kramer |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Fox Infectious Disease research Institute, seattle, Wa, Usa, Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[1].author.id | https://openalex.org/A5008203907 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Michelle Archer |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1330732676 |
| authorships[1].affiliations[0].raw_affiliation_string | Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I1330732676 |
| authorships[1].affiliations[1].raw_affiliation_string | Fox Infectious Disease research Institute, seattle, Wa, Usa |
| authorships[1].institutions[0].id | https://openalex.org/I1330732676 |
| authorships[1].institutions[0].ror | https://ror.org/03y4myd35 |
| authorships[1].institutions[0].type | nonprofit |
| authorships[1].institutions[0].lineage | https://openalex.org/I1330732676 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Infectious Disease Research Institute |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Michelle C Archer |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Fox Infectious Disease research Institute, seattle, Wa, Usa, Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[2].author.id | https://openalex.org/A5064743187 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2684-4722 |
| authorships[2].author.display_name | Mark T. Orr |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1330732676 |
| authorships[2].affiliations[0].raw_affiliation_string | Fox Infectious Disease research Institute, seattle, Wa, Usa |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I1330732676 |
| authorships[2].affiliations[1].raw_affiliation_string | Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[2].institutions[0].id | https://openalex.org/I1330732676 |
| authorships[2].institutions[0].ror | https://ror.org/03y4myd35 |
| authorships[2].institutions[0].type | nonprofit |
| authorships[2].institutions[0].lineage | https://openalex.org/I1330732676 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Infectious Disease Research Institute |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Mark T Orr |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Fox Infectious Disease research Institute, seattle, Wa, Usa, Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[3].author.id | https://openalex.org/A5015486213 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-4895-9117 |
| authorships[3].author.display_name | Natasha Dubois Cauwelaert |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1330732676 |
| authorships[3].affiliations[0].raw_affiliation_string | Fox Infectious Disease research Institute, seattle, Wa, Usa |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I1330732676 |
| authorships[3].affiliations[1].raw_affiliation_string | Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[3].institutions[0].id | https://openalex.org/I1330732676 |
| authorships[3].institutions[0].ror | https://ror.org/03y4myd35 |
| authorships[3].institutions[0].type | nonprofit |
| authorships[3].institutions[0].lineage | https://openalex.org/I1330732676 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Infectious Disease Research Institute |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Natasha Dubois Cauwelaert |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Fox Infectious Disease research Institute, seattle, Wa, Usa, Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[4].author.id | https://openalex.org/A5036997317 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2693-7139 |
| authorships[4].author.display_name | Elyse A. Beebe |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Elyse A Beebe |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5112573052 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Po‐Wei Huang |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1330732676 |
| authorships[5].affiliations[0].raw_affiliation_string | Fox Infectious Disease research Institute, seattle, Wa, Usa |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I1330732676 |
| authorships[5].affiliations[1].raw_affiliation_string | Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[5].institutions[0].id | https://openalex.org/I1330732676 |
| authorships[5].institutions[0].ror | https://ror.org/03y4myd35 |
| authorships[5].institutions[0].type | nonprofit |
| authorships[5].institutions[0].lineage | https://openalex.org/I1330732676 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Infectious Disease Research Institute |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Po-wei D Huang |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Fox Infectious Disease research Institute, seattle, Wa, Usa, Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[6].author.id | https://openalex.org/A5074243944 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-4634-0014 |
| authorships[6].author.display_name | Quinton M. Dowling |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1330732676 |
| authorships[6].affiliations[0].raw_affiliation_string | Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I1330732676 |
| authorships[6].affiliations[1].raw_affiliation_string | Fox Infectious Disease research Institute, seattle, Wa, Usa |
| authorships[6].institutions[0].id | https://openalex.org/I1330732676 |
| authorships[6].institutions[0].ror | https://ror.org/03y4myd35 |
| authorships[6].institutions[0].type | nonprofit |
| authorships[6].institutions[0].lineage | https://openalex.org/I1330732676 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Infectious Disease Research Institute |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Quinton M Dowling |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Fox Infectious Disease research Institute, seattle, Wa, Usa, Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[7].author.id | https://openalex.org/A5004798284 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Alicia M. Schwartz |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1330732676 |
| authorships[7].affiliations[0].raw_affiliation_string | Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I1330732676 |
| authorships[7].affiliations[1].raw_affiliation_string | Fox Infectious Disease research Institute, seattle, Wa, Usa |
| authorships[7].institutions[0].id | https://openalex.org/I1330732676 |
| authorships[7].institutions[0].ror | https://ror.org/03y4myd35 |
| authorships[7].institutions[0].type | nonprofit |
| authorships[7].institutions[0].lineage | https://openalex.org/I1330732676 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Infectious Disease Research Institute |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Alicia M Schwartz |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Fox Infectious Disease research Institute, seattle, Wa, Usa, Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[8].author.id | https://openalex.org/A5029417021 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Dawn M. Fedor |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I1330732676 |
| authorships[8].affiliations[0].raw_affiliation_string | Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I1330732676 |
| authorships[8].affiliations[1].raw_affiliation_string | Fox Infectious Disease research Institute, seattle, Wa, Usa |
| authorships[8].institutions[0].id | https://openalex.org/I1330732676 |
| authorships[8].institutions[0].ror | https://ror.org/03y4myd35 |
| authorships[8].institutions[0].type | nonprofit |
| authorships[8].institutions[0].lineage | https://openalex.org/I1330732676 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Infectious Disease Research Institute |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Dawn M Fedor |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Fox Infectious Disease research Institute, seattle, Wa, Usa, Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[9].author.id | https://openalex.org/A5111380612 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Thomas S. Vedvick |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1330732676 |
| authorships[9].affiliations[0].raw_affiliation_string | Fox Infectious Disease research Institute, seattle, Wa, Usa |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I1330732676 |
| authorships[9].affiliations[1].raw_affiliation_string | Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[9].institutions[0].id | https://openalex.org/I1330732676 |
| authorships[9].institutions[0].ror | https://ror.org/03y4myd35 |
| authorships[9].institutions[0].type | nonprofit |
| authorships[9].institutions[0].lineage | https://openalex.org/I1330732676 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Infectious Disease Research Institute |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Thomas S Vedvick |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Fox Infectious Disease research Institute, seattle, Wa, Usa, Infectious Disease research Institute, 1616 eastlake avenue east, suite 400, seattle, Wa 98102, Usa |
| authorships[10].author.id | https://openalex.org/A5034827691 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-4644-2619 |
| authorships[10].author.display_name | Christopher B. Fox |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Christopher B Fox |
| authorships[10].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.dovepress.com/getfile.php?fileID=42837 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11124 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9991999864578247 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Protein purification and stability |
| related_works | https://openalex.org/W2362777130, https://openalex.org/W4295102914, https://openalex.org/W2094336165, https://openalex.org/W2508856013, https://openalex.org/W2373154855, https://openalex.org/W2898594562, https://openalex.org/W4235529521, https://openalex.org/W2783514584, https://openalex.org/W4317696174, https://openalex.org/W1967224754 |
| cited_by_count | 41 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 9 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 6 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 8 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 9 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 1 |
| counts_by_year[7].year | 2018 |
| counts_by_year[7].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.2147/ijn.s159839 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S101287785 |
| best_oa_location.source.issn | 1176-9114, 1178-2013 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1176-9114 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | International Journal of Nanomedicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310320348 |
| best_oa_location.source.host_organization_name | Dove Medical Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320348 |
| best_oa_location.source.host_organization_lineage_names | Dove Medical Press |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.dovepress.com/getfile.php?fileID=42837 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | International Journal of Nanomedicine |
| best_oa_location.landing_page_url | https://doi.org/10.2147/ijn.s159839 |
| primary_location.id | doi:10.2147/ijn.s159839 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S101287785 |
| primary_location.source.issn | 1176-9114, 1178-2013 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1176-9114 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | International Journal of Nanomedicine |
| primary_location.source.host_organization | https://openalex.org/P4310320348 |
| primary_location.source.host_organization_name | Dove Medical Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320348 |
| primary_location.source.host_organization_lineage_names | Dove Medical Press |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.dovepress.com/getfile.php?fileID=42837 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | International Journal of Nanomedicine |
| primary_location.landing_page_url | https://doi.org/10.2147/ijn.s159839 |
| publication_date | 2018-06-01 |
| publication_year | 2018 |
| referenced_works | https://openalex.org/W1963498445, https://openalex.org/W1970738675, https://openalex.org/W2000643195, https://openalex.org/W2036180283, https://openalex.org/W2289304428, https://openalex.org/W2005501773, https://openalex.org/W1546213590, https://openalex.org/W2047509792, https://openalex.org/W7074149746, https://openalex.org/W1984130714, https://openalex.org/W2528894411, https://openalex.org/W2120415971, https://openalex.org/W2527973249, https://openalex.org/W2528006893, https://openalex.org/W1984612027, https://openalex.org/W2417581277, https://openalex.org/W2079477627, https://openalex.org/W2154192675, https://openalex.org/W1591224424, https://openalex.org/W2016181621, https://openalex.org/W2046693677, https://openalex.org/W2591629102, https://openalex.org/W2001897911, https://openalex.org/W1996859510, https://openalex.org/W2059564760, https://openalex.org/W1968929160, https://openalex.org/W2045889516 |
| referenced_works_count | 27 |
| abstract_inverted_index.a | 8 |
| abstract_inverted_index.in | 4 |
| abstract_inverted_index.of | 7 |
| abstract_inverted_index.aid | 3 |
| abstract_inverted_index.for | 11 |
| abstract_inverted_index.the | 5 |
| abstract_inverted_index.use | 12 |
| abstract_inverted_index.will | 2 |
| abstract_inverted_index.with | 13 |
| abstract_inverted_index.These | 0 |
| abstract_inverted_index.other | 14 |
| abstract_inverted_index.efforts | 1 |
| abstract_inverted_index.similar | 15 |
| abstract_inverted_index.platform | 9 |
| abstract_inverted_index.vaccines. | 16 |
| abstract_inverted_index.development | 6 |
| abstract_inverted_index.formulation | 10 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 90 |
| corresponding_author_ids | https://openalex.org/A5107341610 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| corresponding_institution_ids | https://openalex.org/I1330732676 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.800000011920929 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.85614645 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |